Cargando…
Long term outcome of Aldosteronism after target treatments
There exists a great knowledge gap in terms of long-term effects of various surgical and pharmacological treatments on outcomes among primary aldosteronism (PA) patients. Using a validated algorithm, we extracted longitudinal data for all PA patients diagnosed in 1997–2010 and treated in the Taiwan...
Autores principales: | Wu, Vin-Cent, Wang, Shuo-Meng, Chang, Chia-Hui, Hu, Ya-Hui, Lin, Lian-Yu, Lin, Yen-Hung, Chueh, Shih-Chieh Jeff, Chen, Likwang, Wu, Kwan-Dun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009379/ https://www.ncbi.nlm.nih.gov/pubmed/27586402 http://dx.doi.org/10.1038/srep32103 |
Ejemplares similares
-
Corrigendum: Long term outcome of Aldosteronism after target treatments
por: Wu, Vin-Cent, et al.
Publicado: (2017) -
Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism
por: Chen, Ying-Ying, et al.
Publicado: (2019) -
Risk of sepsis in patients with primary aldosteronism
por: Chan, Chieh-Kai, et al.
Publicado: (2018) -
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes
por: Wu, Vin-Cent, et al.
Publicado: (2017) -
Incidental Congestive Heart Failure in Patients With Aldosterone‐Producing Adenomas
por: Huang, Wei‐Chieh, et al.
Publicado: (2019)